Share on StockTwits
 

Investment analysts at Wells Fargo & Co. initiated coverage on shares of Mednax (NYSE: MD) in a note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm set a “market perform” rating on the stock. The analysts noted that the move was a valuation call.

MD has been the subject of a number of other recent research reports. Analysts at Raymond James reiterated a “buy” rating on shares of Mednax in a research note to investors on Tuesday, May 28th. They now have a $98.00 price target on the stock. Separately, analysts at Jefferies Group raised their price target on shares of Mednax from $95.00 to $108.00 in a research note to investors on Tuesday, May 28th. They now have a “buy” rating on the stock. Finally, analysts at Credit Suisse raised their price target on shares of Mednax from $85.00 to $90.00 in a research note to investors on Tuesday, May 7th. They now have a “neutral” rating on the stock.

Seven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $91.78.

Mednax (NYSE: MD) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.01. The company had revenue of $502.70 million for the quarter, compared to the consensus estimate of $504.24 million. During the same quarter last year, the company posted $0.98 earnings per share. Mednax’s revenue was up 19.0% compared to the same quarter last year. Mednax has set its Q2 guidance at $1.32-1.37 EPS.

MEDNAX, Inc (NYSE: MD) is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialties and anesthesia care.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.